M1 Kliniken AG (M12) - Total Liabilities
Based on the latest financial reports, M1 Kliniken AG (M12) has total liabilities worth €56.26 Million EUR (≈ $65.77 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
M1 Kliniken AG - Total Liabilities Trend (2013–2024)
This chart illustrates how M1 Kliniken AG's total liabilities have evolved over time, based on quarterly financial data. See M1 Kliniken AG short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
M1 Kliniken AG Competitors by Total Liabilities
The table below lists competitors of M1 Kliniken AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lime Technologies AB (publ)
ST:LIME
|
Sweden | Skr556.23 Million |
|
IMC S.A.
F:IM4
|
Germany | €146.23 Million |
|
China Shengmu Organic Milk Limited
F:7OM
|
Germany | €4.17 Billion |
|
Brompton Split Banc Corp
TO:SBC
|
Canada | CA$237.75 Million |
|
NACCO Industries Inc
NYSE:NC
|
USA | $248.54 Million |
|
Tatva Chintan Pharma Chem Limited
NSE:TATVA
|
India | Rs1.53 Billion |
|
P-Duke Technology Co Ltd
TWO:8109
|
Taiwan | NT$836.87 Million |
|
908 Devices Inc
NASDAQ:MASS
|
USA | $52.52 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down M1 Kliniken AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see M12 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how M1 Kliniken AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for M1 Kliniken AG (2013–2024)
The table below shows the annual total liabilities of M1 Kliniken AG from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €53.65 Million ≈ $62.73 Million |
-23.05% |
| 2023-12-31 | €69.73 Million ≈ $81.52 Million |
+29.19% |
| 2022-12-31 | €53.97 Million ≈ $63.10 Million |
-7.27% |
| 2021-12-31 | €58.21 Million ≈ $68.05 Million |
-20.72% |
| 2020-12-31 | €73.42 Million ≈ $85.84 Million |
+198.56% |
| 2019-12-31 | €24.59 Million ≈ $28.75 Million |
+323.19% |
| 2018-12-31 | €5.81 Million ≈ $6.79 Million |
+76.72% |
| 2017-12-31 | €3.29 Million ≈ $3.84 Million |
+70.47% |
| 2016-12-31 | €1.93 Million ≈ $2.26 Million |
-43.88% |
| 2015-12-31 | €3.44 Million ≈ $4.02 Million |
-74.17% |
| 2014-12-31 | €13.31 Million ≈ $15.56 Million |
+83.41% |
| 2013-12-31 | €7.26 Million ≈ $8.48 Million |
-- |
About M1 Kliniken AG
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; abdomino… Read more